GlassScriptPhysician profile
Kelly M Eifling
NPI 1083371728
$12,708.74
in general payments reported to CMS, 2019-2025
20 companies · $2,741 in 2025
The $2,741 reported for 2025 was more than what 96% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $453 · 2023: $576 · 2024: $8,737 · 2025: $2,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,100 · Food and Beverage: $3,929 · Travel and Lodging: $2,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,100.00 |
| Food and Beverage | $3,929.21 |
| Travel and Lodging | $2,024.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,084.99 | 2024-2025 | Mitraclip, Navitor, Aveir |
| Medtronic, INC. | $1,123.52 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Pulseselect |
| Janssen Pharmaceuticals, INC | $248.48 | 2022-2023 | Xarelto |
| Biosense Webster, INC. | $208.74 | 2024-2025 | Carto 3, Qdot Micro Catheter |
| E.R. Squibb & Sons, L.L.C. | $208.53 | 2022-2025 | Camzyos, Cobenfy |
| Pfizer INC. | $141.46 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $109.54 | 2023-2024 | Onpattro |
| Boston Scientific Corporation | $86.50 | 2023-2025 | Emblem Mri S-Icd, Acuity Steerable |
| Sanofi-Aventis U.S. LLC | $79.12 | 2022 | |
| Chiesi USA, INC. | $69.66 | 2024 | Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.94 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $54.81 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.40 | 2023 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $38.89 | 2023 | Inpefa |
| Altathera Pharmaceuticals LLC | $38.22 | 2024-2025 | Sotalol Hydrochloride |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $31.40 | 2025 | Wegovy |
| Bardy Diagnostics, INC. | $29.49 | 2022 | |
| Cvrx, INC. | $20.56 | 2024 | Barostim Neo System |
| Cordis US Corp. | $17.57 | 2024 | Mynx Control |
| Astrazeneca Pharmaceuticals LP | $16.92 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Eifling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.